Fungi are known for causing superficial infections of the nails, skin and hair, but they can also cause systemic infections that can have much more serious health implications. Indeed, over 6.5 million people are infected ...
Oct 21, 2024
0
0
A new diagnosis of Alzheimer's or other dementia often spurs a person to move from their home, new research shows.
Oct 17, 2024
0
0
People over the age of 50 who have severe mental illness are more likely than the general population to experience fragility fractures but may be less likely to get a diagnosis for osteoporosis, finds a new study led by UCL ...
Oct 15, 2024
0
0
Trinity College Dublin researchers based at St James's Hospital have provided important insights into the behavior and metabolic function of a previously largely unknown but crucial natural killer (NK) immune cell resident ...
Oct 10, 2024
0
96
In U.S. adults, hospitalizations involving alcohol withdrawal syndrome (AWS) are common, according to a study published online Oct. 8 in JAMA Network Open.
Oct 10, 2024
0
0
Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, according to a study presented at CHEST 2024, the annual meeting of the American ...
Oct 7, 2024
0
0
Researchers at Karolinska Institutet and the University of Gothenburg have identified a biomarker that could become an important tool for health care in assessing patients with acute COVID-19 infection. The researchers have ...
Oct 4, 2024
0
0
Accelerating the decline in tobacco smoking globally, by decreasing smoking prevalence from current levels to 5% everywhere, could increase life expectancy and prevent millions of premature deaths by 2050, according to a ...
Oct 2, 2024
0
3
Doctors have long known that children who become seriously ill with certain respiratory viruses such as respiratory syncytial virus (RSV) are at elevated risk of developing asthma later in life. What they haven't known is ...
Oct 2, 2024
0
57
The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic ...
Oct 2, 2024
0
0
